Related references
Note: Only part of the references are listed.Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties
Chandran Remya et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists
Jan Konecny et al.
BIOMOLECULES (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo
Martina Kaniakova et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-D-Aspartate receptors
Lukas Gorecki et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Combination Drug Therapy for the Management of Alzheimer's Disease
Md. Tanvir Kabir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Perspective on Multi-target Drugs for Alzheimer's Disease
Ondrej Benek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis
Jiaxun Guo et al.
BRAIN AND BEHAVIOR (2020)
The Role of NMDA Receptors in Alzheimer's Disease
Jinping Liu et al.
FRONTIERS IN NEUROSCIENCE (2019)
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies
Oksana Gerlits et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Low-dose ladostigil for mild cognitive impairment A phase 2 placebo-controlled clinical trial
Lon S. Schneider et al.
NEUROLOGY (2019)
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors
Michael C. Regan et al.
NATURE COMMUNICATIONS (2019)
A simple end-point assay for calcium channel activity
Arunkumar Renganathan Chandrika et al.
CELL CALCIUM (2018)
Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
Stuti Verma et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
Mechanism of NMDA receptor channel block by MK-801 and memantine
Xianqiang Song et al.
NATURE (2018)
7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo
Martina Kaniakova et al.
NEUROPHARMACOLOGY (2018)
Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells
Tzutzuy Ramirez et al.
ARCHIVES OF TOXICOLOGY (2018)
Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation
Eeda Koti Reddy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia
G. Kannan et al.
TRANSLATIONAL PSYCHIATRY (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Probing the Structural Dynamics of the NMDA Receptor Activation by Coarse-Grained Modeling
Wenjun Zheng et al.
BIOPHYSICAL JOURNAL (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Mechanism of NMDA Receptor Inhibition and Activation
Shujia Zhu et al.
CELL (2016)
Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease
Chao Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Functionalised dihydroazo pyrimidine derivatives from Morita-Baylis-Hillman acetates: synthesis and studies against acetylcholinesterase as its inhibitors
Eeda Koti Reddy et al.
RSC ADVANCES (2016)
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
Urban Kosak et al.
SCIENTIFIC REPORTS (2016)
From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease
Daniel I. Perez et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity
Eugenie Nepovimova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A single fraction from Uncaria sinensis exerts neuroprotective effects against glutamate-induced neurotoxicity in primary cultured cortical neurons
Ha Neui Kim et al.
ANATOMY & CELL BIOLOGY (2015)
WEBnm@ v2.0: Web server and services for comparing protein flexibility
Sandhya P. Tiwari et al.
BMC BIOINFORMATICS (2014)
Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
Natalia Guzior et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease
Angel Agis-Torres et al.
CURRENT NEUROPHARMACOLOGY (2014)
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease
Supatra Thiratmatrakul et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
AlzPlatform: An Alzheimer's Disease Domain-Specific Chemogenornics Knowledgebase for Polypharmacology and Target Identification Research
Haibin Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
NMDA receptor structures reveal subunit arrangement and pore architecture
Chia-Hsueh Lee et al.
NATURE (2014)
Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue: implications for glioma epileptogenesis
Xiang Gao et al.
NEUROSURGICAL FOCUS (2014)
SCEDS: protein fragments for molecular replacement in Phaser
Airlie J. McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares et al.
Current Alzheimer Research (2013)
LiCABEDS II. Modeling of Ligand Selectivity for G-Protein-Coupled Cannabinoid Receptors
Chao Ma et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile
Chandran Remya et al.
JOURNAL OF MOLECULAR MODELING (2013)
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials
Ivana Molino et al.
SCIENTIFIC WORLD JOURNAL (2013)
New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
Jonah Cheung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment
A. Minarini et al.
NEUROPHARMACOLOGY (2012)
Selective Regulation of NR2B by Protein Phosphatase-1 for the Control of the NMDA Receptor in Neuroprotection
Melissa Farinelli et al.
PLOS ONE (2012)
iMod: multipurpose normal mode analysis in internal coordinates
Jose Ramon Lopez-Blanco et al.
BIOINFORMATICS (2011)
Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
M. Bajda et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
Erkan Karakas et al.
NATURE (2011)
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Weihong Tu et al.
CELL (2010)
Novel Tacrine-8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols
Maria Rosario Campos-Esparza et al.
CELL CALCIUM (2009)
Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Maria Isabel Fernandez-Bachiller et al.
CHEMMEDCHEM (2009)
Damage and plasticity in adult rat hippocampal trisynaptic circuit neurons after neonatal exposure to glutamate excitotoxicity
I. Gonzalez-Burgos et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2009)
Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain
Jae K. Ryu et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Long-Jun Wu et al.
NEUROTHERAPEUTICS (2009)
REMO: A new protocol to refine full atomic protein models from C-alpha traces by optimizing hydrogen-bonding networks
Yunqi Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
The aging brain
Bruce A. Yankner et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Aryl azoles with neuroprotective activity - Parallel synthesis and attempts at target identification
Giuseppe Cocconcelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Traumatic brain injury: Can the consequences be stopped?
Eugene Park et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates
Lei Fang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Bio3d: an R package for the comparative analysis of protein structures
Barry J. Grant et al.
BIOINFORMATICS (2006)
Involvement of oxidative stress in Alzheimer disease
Akihiko Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
G Amadoro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Crystal structures of the GluR5 and GluR6 ligand binding cores: Molecular mechanisms underlying kainate receptor selectivity
ML Mayer
NEURON (2005)
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Deciphering the molecular basis of memory failure in Alzheimer's disease
DM Walsh et al.
NEURON (2004)
ElNemo:: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement
K Suhre et al.
NUCLEIC ACIDS RESEARCH (2004)
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors
E Arias et al.
NEUROPHARMACOLOGY (2004)
Treatment of Alzheimer's disease: current status and new perspectives
E Scarpini et al.
LANCET NEUROLOGY (2003)
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
MA Rogawski et al.
CNS DRUG REVIEWS (2003)
Galantamine hydrobromide: An agent for Alzheimer's disease
V Zarotsky et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2003)
Neurobiology of butyrylcholinesterase
S Darvesh et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Acetylcholinesterase - A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease
HM Greenblatt et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
JJ Miguel-Hidalgo et al.
BRAIN RESEARCH (2002)
Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway
C Lesuisse et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Homodimeric tacrine congeners as acetylcholinesterase inhibitors
MK Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1-40) in rat
R Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type
A Law et al.
BRAIN RESEARCH REVIEWS (2001)
Glutamate and aspartate impair memory retention and damage hypothalamic neurons in adult mice
CH Park et al.
TOXICOLOGY LETTERS (2000)
Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease
MW Jann
PHARMACOTHERAPY (2000)
Share Paper
